Results for tag: "Tardive Dyskinesia Drug"

Tardive Dyskinesia (TD) is a neurological disorder characterized by involuntary, repetitive movements of the face, tongue, and extremities. It is caused by long-term use of certain medications, primarily antipsychotics, used to treat mental health disorders. As a result, the TD drug market is a subset of the Central Nervous System (CNS) drug market. TD drugs are used to reduce the severity of TD symptoms, such as involuntary movements, and to prevent the recurrence of symptoms. These drugs are typically prescribed in combination with antipsychotics, as well as other medications, to reduce the risk of TD. The TD drug market is highly competitive, with a number of companies offering various products. These products include both generic and branded drugs, as well as combination therapies. Companies in the TD drug market include AbbVie, Allergan, AstraZeneca, Eli Lilly, Johnson & Johnson, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more